NewsSOS
An investor inquiry into claims against Elicio Therapeutics, Inc. (NASDAQ: ELTX) is underway, Pomerantz LLP disclosed, with the firm directing shareholders to contact attorney Danielle Peyton.
The release did not name specific allegations or a period under review. What the firm announced Pomerantz LLP said it is investigating claims on behalf of investors of Elicio Therapeutics.
The release offered no detail on the timeline or scope of the inquiry. Elicio Therapeutics trades on the Nasdaq exchange under the ticker ELTX.
How to reach the firm Investors seeking information were directed to Danielle Peyton at newaction@pomlaw.com or by phone at 646-581-9980, ext. The firm issued the disclosure from New York.
Keep reading